November 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Jordan Agay: Why We Need to Track the Neurological Costs of Anemia

Jordan Agay/LinkedIn

Jul 23, 2026, 19:30

Jordan Agay: Why We Need to Track the Neurological Costs of Anemia

Jordan Agay, Public Health and Bioinformatics Student at The George Washington University and Clinical Product Strategy and Feedback Intern at hc1, shared a post on LinkedIn:

“Anemia’s most visible effects are physical. Its least visible may be neurological.

Iron deficiency, with or without anemia, is associated with impaired attention, reduced processing speed, and cognitive fatigue.

In older adults, persistent anemia correlates with accelerated cognitive decline and increased dementia risk.

In pregnant women, iron deficiency during pregnancy is associated with measurable neurodevelopmental impacts in the infant.

These are not rare outcomes.

They are poorly tracked and underrecognized effects of a condition that often goes unmanaged for months.

The challenge is that cognitive effects do not appear on a lab panel.

But the lab trends that predict them do, if someone is looking at the trajectory rather than the snapshot.

hc1’s Clinical IQ Anemia Management Module tracks hemoglobin and iron status longitudinally across patient encounters, surfacing declining trends before they reach thresholds that already signal significant physiological impact.

That earlier visibility is what creates room to intervene and potentially protect outcomes that extend well beyond hemoglobin levels.”

Jordan Agay